IBDHorizons June 23rd Dialogue
Navigating Ulcerative Colitis Therapies Today (Peds focus)
Moderated by Dr. Ghassan Wahbeh and Dr. Joel Rosh
Based on emerging data, new publications, and latest developments at the recent national and international IBD meetings, the program will focus on a practical approach to managing young adults with UC. Given the expansive therapeutic options, the discussion will follow a UC case from diagnosis onwards with the goal of sharing experience between the moderators and attendees. Both moderators bring wide expertise as professors in the field of IBD. Discussion will encompass the different mechanisms of action of the available therapies, including biologics/biosimilars and small molecules, efficacy, and safety profiles, integration into today’s practice, individualization of therapy and preventing complications.
Dinner is always included at our Dialogue events. For virtual programs, we provide meal vouchers through UberEats.
Date: Wednesday June 23, 2021
Time: 6:00-8:30 PM (PST)
Location: IBDHorizons virtual digital platform
Format: Interactive virtual roundtable case discussions focused on managing Ulcerative Colitis in young patients
Dinner: Provided through UberEats
- Dr. Ghassan Wahbeh, Professor – University of Washington, Seattle, WA
- Dr. Joel Rosh, Professor – ICAHN School of Medicine, Mt Sinai School of Medicine, NY
If you are interested in attending this event or would like to host one locally with your practice, reach out to email@example.com
AbbVie Gastroenterology – Immunology Specialist
Western WA & AK
Ghassan WahbehMD, Director of the Inflammatory Bowel Disease Center at Seattle Children’s Hospital
Ghassan Wahbeh, MD, is the director of the Inflammatory Bowel Disease Center at Seattle Children’s Hospital. He is a Professor of Pediatrics and Gastroenterology at the University of Washington School of Medicine. Dr. Wahbeh’s clinical focus is in advanced care for children, adolescents, and young adults with Crohn’s Disease and Ulcerative Colitis, including advanced therapeutics and pre and post-surgery IBD management. Dr. Wahbeh’s research interests include advanced management of moderate and severe colitis in the outpatient and inpatient setting, managing complicated Crohn’s disease including fistulizing and stricturing phenotypes, mucosal healing in IBD, navigating surgical options in IBD and novel therapies. Dr. Wahbeh is actively involved as teaching faculty in medical student education, resident training, and fellow physician specialty training. He is the honored recipient of the Outstanding Teaching Faculty Award, as well as the Family Choice Award, and the Northwest Crohns & Colitis Foundation service award. He continues to serve as a member of the National Professional Education Committee and the Northwest Medical Advisory Committee of the Crohns and Colitis Foundation of America.
Joel RoshMD, Pediatric Gastroenterologist, Director, Associate Professor
Dr. Rosh, director, Pediatric Gastroenterology, has been practicing Pediatric Gastroenterology for more than 12 years and is board certified in Pediatrics, Pediatric Gastroenterology and Nutrition. Joel R. Rosh received an Honors Degree from Brown University and his Medical Degree from the Albert Einstein College of Medicine in New York. His postdoctoral training included an internship and residency at the Children’s Hospital of New York- Columbia Presbyterian Medicfal Center and a Fellowship in Pediatric Gastroenterology at the Mount Sinai Medical Center in New York. He remained on faculty at Mount Sinai until 1994 when he moved to the Goryeb Children’s Hospital/Atlantic Health in Morristown, NJ where he founded the Division of Pediatric Gastroenterology and the Pediatric IBD Center.
Dr. Rosh is a long-standing member of many professional societies and has served as an advisor to the FDA as well as numerous foundations and advisory bodies. He has served as National Chairman of the CCFA Pediatric Education Committee, a National Councilor for NASPGHAN and is on the editorial boards of the Journal of Pediatric Gastroenterology and Nutrition and the Journal of Clinical Gastroenterology. Dr. Rosh has been honored as the CCFA Physician of the Year, New Jersey Chapter; the New Jersey Pediatric Society Physician Recognition Award; and Castle Connolly’s New York Metro Area Top Doctor (1998-2016). Dr. Rosh frequently serves at the regional and national level as an IBD speaker and educator. He is widely published in the field of pediatric IBD and his current research focus is the safety and efficacy of standard as well as emergy pharmacotherapy.